Literature DB >> 19701678

Breast cancer in Singapore: some perspectives.

Ana Richelia Jara-Lazaro1, Shyamala Thilagaratnam, Puay Hoon Tan.   

Abstract

Breast cancer is the commonest malignancy among Singapore women, accounting for 29.7% of all female cancers, with an age-standardized rate of 54.9 per 100,000 per year. It has been the most frequent cancer in Singapore women for the last 30 years, with the highest rates previously reported in those aged between 45 and 49 years, but with a more recent observation of a change in peak age group to women in their late 50s. About 1,100 new cases are diagnosed annually and approximately 270 women die in Singapore each year from breast cancer. In the multiethnic population of Singapore, it has been noted that rising breast cancer incidence is consistent across all three ethnic groups (Chinese, Malays, and Indians). Singapore has among the highest breast cancer incidence in Asia. Possible explanations include rapid urbanization, improvement in socio-economic status, and adoption of a western lifestyle. Our experience with the Singapore breast screening pilot project (1994-1997) and the national breast-screening program (BreastScreen Singapore) has led to increased understanding of this disease in the country. Data from the pilot project showed that breast screening is just as effective in a predominantly Asian population as in the west. Early breast cancer accounted for most breast cancers detected, with pre-invasive ductal carcinoma in situ (DCIS) comprising 26% of all screen-detected cancers in the pilot study. In the currently on-going BreastScreen Singapore, DCIS forms >30% of all breast cancers among pre-menopausal women, a relatively high proportion probably accounted for partially by the greater participation of women aged between 40 and 49 years. Despite the ready availability of subsidized mammographic screening, there are still women in Singapore who present with locally advanced breast cancer. Clinical management of an increasing number of women with breast cancer embraces a multidisciplinary team-based approach, with regular discussions of therapeutic strategies at tumor boards. In order to improve breast cancer diagnostics and therapeutics in our country, it is important that there are continual breast cancer and breast disease-related educational activities for medical professionals engaged in diagnosing and managing breast cancer. The role of public education in raising awareness is also essential.

Entities:  

Mesh:

Year:  2009        PMID: 19701678     DOI: 10.1007/s12282-009-0155-3

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  7 in total

1.  Time trends of cancer incidence in urban beijing, 1998-2007.

Authors:  Ning Wang; Wei-Xing Zhu; Xiu-Mei Xing; Lei Yang; Ping-Ping Li; Wei-Cheng You
Journal:  Chin J Cancer Res       Date:  2011-03       Impact factor: 5.087

2.  Barriers to early presentation of self-discovered breast cancer in Singapore and Malaysia: a qualitative multicentre study.

Authors:  Jennifer N W Lim; Barbara Potrata; Leonardo Simonella; Celene W Q Ng; Tar-Ching Aw; Maznah Dahlui; Mikael Hartman; Rifhan Mazlan; Nur Aishah Taib
Journal:  BMJ Open       Date:  2015-12-21       Impact factor: 2.692

3.  Occupational exposure to endocrine disrupting substances and the risk of breast Cancer: the Singapore Chinese health study.

Authors:  Teofilia Acheampong; Jian-Min Yuan; Woon Puay Koh; Aizhen Jin; Andrew Odegaard
Journal:  BMC Public Health       Date:  2018-07-28       Impact factor: 3.295

4.  Polygenic risk scores for prediction of breast cancer risk in Asian populations.

Authors:  Weang-Kee Ho; Mei-Chee Tai; Joe Dennis; Xiang Shu; Jingmei Li; Peh Joo Ho; Iona Y Millwood; Kuang Lin; Yon-Ho Jee; Su-Hyun Lee; Nasim Mavaddat; Manjeet K Bolla; Qin Wang; Kyriaki Michailidou; Jirong Long; Eldarina Azfar Wijaya; Tiara Hassan; Kartini Rahmat; Veronique Kiak Mien Tan; Benita Kiat Tee Tan; Su Ming Tan; Ern Yu Tan; Swee Ho Lim; Yu-Tang Gao; Ying Zheng; Daehee Kang; Ji-Yeob Choi; Wonshik Han; Han-Byoel Lee; Michiki Kubo; Yukinori Okada; Shinichi Namba; Sue K Park; Sung-Won Kim; Chen-Yang Shen; Pei-Ei Wu; Boyoung Park; Kenneth R Muir; Artitaya Lophatananon; Anna H Wu; Chiu-Chen Tseng; Keitaro Matsuo; Hidemi Ito; Ava Kwong; Tsun L Chan; Esther M John; Allison W Kurian; Motoki Iwasaki; Taiki Yamaji; Sun-Seog Kweon; Kristan J Aronson; Rachel A Murphy; Woon-Puay Koh; Chiea-Chuen Khor; Jian-Min Yuan; Rajkumar Dorajoo; Robin G Walters; Zhengming Chen; Liming Li; Jun Lv; Keum-Ji Jung; Peter Kraft; Paul D B Pharoah; Alison M Dunning; Jacques Simard; Xiao-Ou Shu; Cheng-Har Yip; Nur Aishah Mohd Taib; Antonis C Antoniou; Wei Zheng; Mikael Hartman; Douglas F Easton; Soo-Hwang Teo
Journal:  Genet Med       Date:  2021-12-15       Impact factor: 8.864

5.  Cost effectiveness analysis of a polygenic risk tailored breast cancer screening programme in Singapore.

Authors:  Jerry Zeng Yang Wong; Jia Hui Chai; Yen Shing Yeoh; Nur Khaliesah Mohamed Riza; Jenny Liu; Yik-Ying Teo; Hwee Lin Wee; Mikael Hartman
Journal:  BMC Health Serv Res       Date:  2021-04-23       Impact factor: 2.655

6.  Prevalence and Determinants of Adherence to Oral Adjuvant Endocrine Therapy among Breast Cancer Patients in Singapore.

Authors:  Eskinder Eshetu Ali; Ka Lok Cheung; Chee Ping Lee; Jo Lene Leow; Kevin Yi-Lwern Yap; Lita Chew
Journal:  Asia Pac J Oncol Nurs       Date:  2017 Oct-Dec

7.  Incidence of breast cancer attributable to breast density, modifiable and non-modifiable breast cancer risk factors in Singapore.

Authors:  Peh Joo Ho; Hannah Si Hui Lau; Weang Kee Ho; Fuh Yong Wong; Qian Yang; Ken Wei Tan; Min-Han Tan; Wen Yee Chay; Kee Seng Chia; Mikael Hartman; Jingmei Li
Journal:  Sci Rep       Date:  2020-01-16       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.